Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives

The synthesis of a series of 1-amino-substituted pyrido[4,3-b]carbazole derivatives, based on the substitution of corresponding 1-chloroellipticines, is reported. The cytotoxic properties on tumor cells grown in vitro, the in vivo acute toxicity of the most potent in vitro cytotoxic compounds, and t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1980-11, Vol.23 (11), p.1212
Hauptverfasser: Ducrocq, C, Wendling, F, Tourbez-Perrin, M, Rivalle, C, Tambourin, P, Pochon, F, Bisagni, E, Chermann, J C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 1212
container_title Journal of medicinal chemistry
container_volume 23
creator Ducrocq, C
Wendling, F
Tourbez-Perrin, M
Rivalle, C
Tambourin, P
Pochon, F
Bisagni, E
Chermann, J C
description The synthesis of a series of 1-amino-substituted pyrido[4,3-b]carbazole derivatives, based on the substitution of corresponding 1-chloroellipticines, is reported. The cytotoxic properties on tumor cells grown in vitro, the in vivo acute toxicity of the most potent in vitro cytotoxic compounds, and the antitumor properties toward the L1210 leukemia system are described. No correlation between the apparent association constant to DNA and the in vitro cytotoxicity or the in vito antitumor efficiency could be observed in this series. 9-Hydroxylated derivatives were more cytotoxic in vitro than the corresponding 9-methoxylated compounds. However, their antitumor efficiencies on the in vivo experimental systems do not confirm the advantage of demethylation. The presence of a [(dialkylamino)alkyl]amino side chain at the 1 position of ellipticines increases the antitumor potency: 1-[[3-(diethylamino)propyl]amino]-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (5) is a very potent antitumor compound (% ILS of 134 on the L1210 leukemia system).
doi_str_mv 10.1021/jm00185a012
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_7452670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>7452670</sourcerecordid><originalsourceid>FETCH-LOGICAL-p138t-936749f9be9ad83383d8ce23ba92f785a5eedcca6b30bcadc2f6ba9ce7a35c923</originalsourceid><addsrcrecordid>eNotj0tLAzEUhbNQaq2uXAv5A9Ekt_PIUoovKLhQ1yWT3KG3zIskMzL-egfs6sA5nA8-xu6UfFBSq8dTK6UqMyuVvmBrKbUWOtdwxa5jPEkpQWlYsVWxzXReyDVrP1MYXRoDCusSTZRmHrCxifouHmmInDpuecRAGHlf8w5_mpnHuUtHjPSLnithW-p6EccqJkpjWjpsGhoSOeqQ--U7LcAJ4w27rG0T8facG_b98vy1exP7j9f33dNeDArKJAzkxdbUpkJjfQlQgi8daqis0XWx2GWI3jmbVyArZ73Tdb5sDgsLmTMaNuz-nzuMVYv-MARqbZgPZ234AyUTW98</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives</title><source>ACS Publications</source><source>MEDLINE</source><creator>Ducrocq, C ; Wendling, F ; Tourbez-Perrin, M ; Rivalle, C ; Tambourin, P ; Pochon, F ; Bisagni, E ; Chermann, J C</creator><creatorcontrib>Ducrocq, C ; Wendling, F ; Tourbez-Perrin, M ; Rivalle, C ; Tambourin, P ; Pochon, F ; Bisagni, E ; Chermann, J C</creatorcontrib><description>The synthesis of a series of 1-amino-substituted pyrido[4,3-b]carbazole derivatives, based on the substitution of corresponding 1-chloroellipticines, is reported. The cytotoxic properties on tumor cells grown in vitro, the in vivo acute toxicity of the most potent in vitro cytotoxic compounds, and the antitumor properties toward the L1210 leukemia system are described. No correlation between the apparent association constant to DNA and the in vitro cytotoxicity or the in vito antitumor efficiency could be observed in this series. 9-Hydroxylated derivatives were more cytotoxic in vitro than the corresponding 9-methoxylated compounds. However, their antitumor efficiencies on the in vivo experimental systems do not confirm the advantage of demethylation. The presence of a [(dialkylamino)alkyl]amino side chain at the 1 position of ellipticines increases the antitumor potency: 1-[[3-(diethylamino)propyl]amino]-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (5) is a very potent antitumor compound (% ILS of 134 on the L1210 leukemia system).</description><identifier>ISSN: 0022-2623</identifier><identifier>DOI: 10.1021/jm00185a012</identifier><identifier>PMID: 7452670</identifier><language>eng</language><publisher>United States</publisher><subject>Alkaloids - chemical synthesis ; Animals ; Antineoplastic Agents ; Cell Survival - drug effects ; Chemical Phenomena ; Chemistry ; Ellipticines - chemical synthesis ; Ellipticines - metabolism ; Ellipticines - pharmacology ; Lethal Dose 50 ; Mice ; Neoplasms, Experimental - drug therapy ; Structure-Activity Relationship</subject><ispartof>Journal of medicinal chemistry, 1980-11, Vol.23 (11), p.1212</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7452670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ducrocq, C</creatorcontrib><creatorcontrib>Wendling, F</creatorcontrib><creatorcontrib>Tourbez-Perrin, M</creatorcontrib><creatorcontrib>Rivalle, C</creatorcontrib><creatorcontrib>Tambourin, P</creatorcontrib><creatorcontrib>Pochon, F</creatorcontrib><creatorcontrib>Bisagni, E</creatorcontrib><creatorcontrib>Chermann, J C</creatorcontrib><title>Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives</title><title>Journal of medicinal chemistry</title><addtitle>J Med Chem</addtitle><description>The synthesis of a series of 1-amino-substituted pyrido[4,3-b]carbazole derivatives, based on the substitution of corresponding 1-chloroellipticines, is reported. The cytotoxic properties on tumor cells grown in vitro, the in vivo acute toxicity of the most potent in vitro cytotoxic compounds, and the antitumor properties toward the L1210 leukemia system are described. No correlation between the apparent association constant to DNA and the in vitro cytotoxicity or the in vito antitumor efficiency could be observed in this series. 9-Hydroxylated derivatives were more cytotoxic in vitro than the corresponding 9-methoxylated compounds. However, their antitumor efficiencies on the in vivo experimental systems do not confirm the advantage of demethylation. The presence of a [(dialkylamino)alkyl]amino side chain at the 1 position of ellipticines increases the antitumor potency: 1-[[3-(diethylamino)propyl]amino]-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (5) is a very potent antitumor compound (% ILS of 134 on the L1210 leukemia system).</description><subject>Alkaloids - chemical synthesis</subject><subject>Animals</subject><subject>Antineoplastic Agents</subject><subject>Cell Survival - drug effects</subject><subject>Chemical Phenomena</subject><subject>Chemistry</subject><subject>Ellipticines - chemical synthesis</subject><subject>Ellipticines - metabolism</subject><subject>Ellipticines - pharmacology</subject><subject>Lethal Dose 50</subject><subject>Mice</subject><subject>Neoplasms, Experimental - drug therapy</subject><subject>Structure-Activity Relationship</subject><issn>0022-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNotj0tLAzEUhbNQaq2uXAv5A9Ekt_PIUoovKLhQ1yWT3KG3zIskMzL-egfs6sA5nA8-xu6UfFBSq8dTK6UqMyuVvmBrKbUWOtdwxa5jPEkpQWlYsVWxzXReyDVrP1MYXRoDCusSTZRmHrCxifouHmmInDpuecRAGHlf8w5_mpnHuUtHjPSLnithW-p6EccqJkpjWjpsGhoSOeqQ--U7LcAJ4w27rG0T8facG_b98vy1exP7j9f33dNeDArKJAzkxdbUpkJjfQlQgi8daqis0XWx2GWI3jmbVyArZ73Tdb5sDgsLmTMaNuz-nzuMVYv-MARqbZgPZ234AyUTW98</recordid><startdate>198011</startdate><enddate>198011</enddate><creator>Ducrocq, C</creator><creator>Wendling, F</creator><creator>Tourbez-Perrin, M</creator><creator>Rivalle, C</creator><creator>Tambourin, P</creator><creator>Pochon, F</creator><creator>Bisagni, E</creator><creator>Chermann, J C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>198011</creationdate><title>Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives</title><author>Ducrocq, C ; Wendling, F ; Tourbez-Perrin, M ; Rivalle, C ; Tambourin, P ; Pochon, F ; Bisagni, E ; Chermann, J C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p138t-936749f9be9ad83383d8ce23ba92f785a5eedcca6b30bcadc2f6ba9ce7a35c923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Alkaloids - chemical synthesis</topic><topic>Animals</topic><topic>Antineoplastic Agents</topic><topic>Cell Survival - drug effects</topic><topic>Chemical Phenomena</topic><topic>Chemistry</topic><topic>Ellipticines - chemical synthesis</topic><topic>Ellipticines - metabolism</topic><topic>Ellipticines - pharmacology</topic><topic>Lethal Dose 50</topic><topic>Mice</topic><topic>Neoplasms, Experimental - drug therapy</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ducrocq, C</creatorcontrib><creatorcontrib>Wendling, F</creatorcontrib><creatorcontrib>Tourbez-Perrin, M</creatorcontrib><creatorcontrib>Rivalle, C</creatorcontrib><creatorcontrib>Tambourin, P</creatorcontrib><creatorcontrib>Pochon, F</creatorcontrib><creatorcontrib>Bisagni, E</creatorcontrib><creatorcontrib>Chermann, J C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ducrocq, C</au><au>Wendling, F</au><au>Tourbez-Perrin, M</au><au>Rivalle, C</au><au>Tambourin, P</au><au>Pochon, F</au><au>Bisagni, E</au><au>Chermann, J C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J Med Chem</addtitle><date>1980-11</date><risdate>1980</risdate><volume>23</volume><issue>11</issue><spage>1212</spage><pages>1212-</pages><issn>0022-2623</issn><abstract>The synthesis of a series of 1-amino-substituted pyrido[4,3-b]carbazole derivatives, based on the substitution of corresponding 1-chloroellipticines, is reported. The cytotoxic properties on tumor cells grown in vitro, the in vivo acute toxicity of the most potent in vitro cytotoxic compounds, and the antitumor properties toward the L1210 leukemia system are described. No correlation between the apparent association constant to DNA and the in vitro cytotoxicity or the in vito antitumor efficiency could be observed in this series. 9-Hydroxylated derivatives were more cytotoxic in vitro than the corresponding 9-methoxylated compounds. However, their antitumor efficiencies on the in vivo experimental systems do not confirm the advantage of demethylation. The presence of a [(dialkylamino)alkyl]amino side chain at the 1 position of ellipticines increases the antitumor potency: 1-[[3-(diethylamino)propyl]amino]-5,11-dimethyl-6H-pyrido[4,3-b]carbazole (5) is a very potent antitumor compound (% ILS of 134 on the L1210 leukemia system).</abstract><cop>United States</cop><pmid>7452670</pmid><doi>10.1021/jm00185a012</doi></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1980-11, Vol.23 (11), p.1212
issn 0022-2623
language eng
recordid cdi_pubmed_primary_7452670
source ACS Publications; MEDLINE
subjects Alkaloids - chemical synthesis
Animals
Antineoplastic Agents
Cell Survival - drug effects
Chemical Phenomena
Chemistry
Ellipticines - chemical synthesis
Ellipticines - metabolism
Ellipticines - pharmacology
Lethal Dose 50
Mice
Neoplasms, Experimental - drug therapy
Structure-Activity Relationship
title Structure-activity relationships in a series of newly synthesized 1-amino-substituted ellipticine derivatives
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T14%3A22%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structure-activity%20relationships%20in%20a%20series%20of%20newly%20synthesized%201-amino-substituted%20ellipticine%20derivatives&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ducrocq,%20C&rft.date=1980-11&rft.volume=23&rft.issue=11&rft.spage=1212&rft.pages=1212-&rft.issn=0022-2623&rft_id=info:doi/10.1021/jm00185a012&rft_dat=%3Cpubmed%3E7452670%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/7452670&rfr_iscdi=true